Careers Open Positions Benefits Contact Us Menu ALEXZA PHARMACEUTICALS OUR PARTNERS UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is continuously working to advance science and embrace new knowledge. Patients inspire UCB to deliver value through cutting-edge science, innovative drugs, and practical solutions—so that they and their care givers can get on with their lives. With more than 7500 people in approximately 40 countries, UCB is listed on the Euronext Brussels where its Global HQ is based. Find out more at UCB.com and follow them on Twitter: @UCB_news. Through an exclusive licensing agreement, Lee’s Pharm will develop and commercialize ADASUVE (Staccato loxapine) in China and Staccato fentanyl in China and Southeast Asia. Lee’s Pharmaceutical Holdings Limited (Lee’s Pharm) is a public biopharmaceutical company with over 20 years of operation in China’s pharmaceutical industry. It is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing in China with global perspectives and currently markets 14 products in the PRC. Lee’s Pharm focuses on several different areas such as cardiovascular and infectious diseases, dermatology, oncology, gynecology, ophthalmology and others. It has more than 40 products under different development stages stemming from both internal R&D as well as from the recent acquisition of licensing and distribution rights from various US, European and Japanese companies. For more information, visit Lee’s Pharm. Through a commercial partnership for ADASUVE® (loxapine) inhalation powder (Staccato® loxapine), Alexza’s lead product, Ferrer is commercializing ADASUVE in Europe, Latin America, Russia, the CIS countries, the Middle East and North Africa countries, Korea, the Philippines and Thailand. Founded in 1959, Ferrer is a privately held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer’s human healthcare products are commercialized in more than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors. For more information, visit Ferrer. For more information about our programs click here. For more information about pipeline opportunities click here. To discuss partnership and licensing opportunities, please contact our Business Development Group ©2021 ALEXZA® ALEXZA PHARMACEUTICALS Corporate Headquarters 2091 Stierlin Court Mountain View, CA 94043 TEL: 650 944 7000 FAX: 650 944 7999 About Pipeline Partnering Contact Us Privacy Policy Terms of Use Disclaimer Staccato OBT